深度学习助力发现抗淋病奈瑟菌抗生素
其中两个化合物结构新颖、对多重耐药菌株保持活性、具有快速杀菌和低耐药频率,并在人阴道芯片和小鼠阴道感染模型中显示早期疗效。
要点
- 图神经网络模型可增补高通量筛选,高效发现窄谱抗淋病奈瑟菌活性分子。
- 两个新结构化合物对多重耐药菌株保持体外活性,具快速杀菌和低耐药频率。
核心结论
- 深度学习模型可加速发现针对淋病奈瑟菌的选择性抗菌先导化合物,以应对耐药危机。
研究设计与样本
- 对38,650个小分子进行淋病奈瑟菌生长抑制表型测试,训练预测性图神经网络模型。
- 将模型性能与包括大语言模型在内的其他架构进行基准比较。
主要发现
- 图神经网络比其他架构更准确识别出结构不同于训练集和已知抗生素的活性、类药分子。
- 213个验证化合物中83个(39%)抑制淋病奈瑟菌生长。
- 两个化合物与现有抗生素结构不同,体外对多重耐药淋病奈瑟菌菌株保持效力,具良好选择性指数,快速杀菌且耐药频率低。
- 蛋白质组学研究揭示两化合物作用机制不同,其一靶向参与肽聚糖合成的丙氨酸消旋酶。
- 两化合物在人阴道芯片感染模型和小鼠阴道感染模型中显示降低淋病奈瑟菌滴度的早期前景。
临床怎么用
- 图神经网络可增补高通量筛选,提升抗淋病奈瑟菌活性分子发现效率。
- 发现的窄谱化合物可作为先导,推进应对多重耐药淋病奈瑟菌的药物开发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neisseria gonorrhoeae is a common Gram-negative pathogen with increasing resistance to all recommended antibiotics. There is a critical need to improve the efficiency of the antibiotic hit discovery process to replenish the drug development pipeline. Here, we show that deep learning models can augment high-throughput screens to identify readily available molecules with narrow-spectrum activity against difficult-to-treat strains of N. gonorrhoeae. We phenotypically tested 38,650 small molecules for N. gonorrhoeae growth inhibition to train a predictive graph neural network (GNN) model. We benchmarked the model's performance against other architectures, including a large language model, and found that GNNs more accurately identify active, drug-like molecules that are structurally distinct from the training set and known antibiotics. Using the model to virtually screen ~6 million compounds, we identified 213 compounds for experimental validation and found that 83 (39%) inhibited N. gonorrhoeae growth. Two of these compounds were structurally dissimilar to existing antibiotics, maintained potency against multidrug-resistant N. gonorrhoeae strains in vitro, exhibited promising selectivity indices, and were rapidly bactericidal with low frequencies of resistance. Proteomic studies revealed their distinct mechanisms of action, with one compound targeting alanine racemase, an enzyme involved in the essential process of peptidoglycan synthesis. Furthermore, the compounds showed early promise in reducing N. gonorrhoeae titers in a human vagina-on-a-chip infection model and a mouse vaginal infection model. Our work establishes the deep learning-enabled discovery of selective antibacterial compounds against N. gonorrhoeae as a much-needed hit discovery tool to address the growing crisis of antimicrobial resistance for this pathogen.
引用
- Anahtar MN, Valeri JA, Modaresi SM, et al. Deep learning-enabled discovery of antibiotics effective against Neisseria gonorrhoeae. Sci Transl Med. 2026. PMID: 42308330. doi:10.1126/scitranslmed.ads4699
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。